| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
3 companies
Broadwood Partners, L.P. is a Director, 10% Owner at Lineage Cell Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 24 buys and 0 sells.
Estimated insider holdings value: $582.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2019 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 2,000,000 | $1.66 | $3,320,000.00 | +9.9% | |
| Aug 15, 2019 | LCTX Lineage Cell Therapeutics, Inc. | Director, 10% Owner | Buy | 24,553 | $0.98 | $24,045.30 | - | |
| Jul 2, 2019 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 1,000,000 | $2.00 | $2,000,000.00 | +5.8% | |
| May 3, 2019 | STAA Staar Surgical Co | 10% Owner | Buy | 100,000 | $22.23 | $2,223,000.00 | +0.5% | |
| Feb 8, 2019 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 533,333 | $3.75 | $1,999,998.75 | +3.4% | |
| Mar 28, 2018 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 3,968,254 | $1.26 | $5,000,000.04 | +35.6% | |
| Oct 13, 2017 | LCTX Lineage Cell Therapeutics, Inc. | Director, 10% Owner | Buy | 2,692,307 | $2.60 | $6,999,998.20 | +4.7% | |
| Aug 22, 2017 | LCTX Lineage Cell Therapeutics, Inc. | Director, 10% Owner | Buy | 10,000 | $2.60 | $25,955.00 | - | |
| Jul 31, 2017 | LCTX Lineage Cell Therapeutics, Inc. | Director, 10% Owner | Buy | 150,000 | $2.80 | $420,000.00 | +0.3% | |
| Feb 15, 2017 | LCTX Lineage Cell Therapeutics, Inc. | Director, 10% Owner | Buy | 2,222,222 | $2.70 | $5,999,999.40 | +4.3% |